Switches in HER2 status (HER2 flip) between primary breast tumors and brain metastasis or disease recurrence have been reported in the recent literature, highlighting that CNS metastatic disease can evolve and have different biological features compared to the primary tumor. This evidence concerns the gene ERBB2 and metastatic neoplasm.